HK Genomics,

founded in January 2019 as a venture company, has made several attempts to develop and produce enzymes and monoclonal antibodies for molecular diagnostic kits and to raise their activities. We are aiming at developing enzymes and supplying them to research institutes or for academic researches and furthermore, world-class molecular diagnostic kits with these enzymes for the benefit of the world.